Removing Commercialization Roadblocks in Microbial Biostimulants to Create Successful Products

• Identifying the most common scale-up, manufacturing, and market-entry failures seen in commercial programs
• Aligning formulation, production, and field performance with buyer expectations and regional constraints
• Differentiating products in crowded markets by targeting unmet needs and defensible value propositions

Speakers:

Chris Wooley

Brand Portfolio Manager

Wilbur-Ellis Holdings Inc.